By Will Boggs, MD NEW YORK (Reuters Health) – Temsirolimus does not improve progression-free survival in metastatic renal cell carcinoma (RCC) compared to standard treatment, according to results…
NEW YORK (Reuters Health) – In patients with potentially resectable colorectal liver metastases, the use of combined PET and CT imaging (PET-CT) identifies those with occult extrahepatic disease…
Recent Videos in Reuters Health • The Doctor’s Channel Newscast Page 260
NEW YORK (Reuters Health) – In older prostate cancer patients with a biochemical recurrence, cancer anxiety predicts earlier use of androgen deprivation therapy (ADT), new research shows. This…
NEW YORK (Reuters Health) – Vitamin D deficiency is “rampant” among children with chronic kidney disease, and the prevalence of severe deficiency has increased over the last two…
NEW YORK (Reuters Health) – Consuming seven glasses or more of wine each week may reduce the risk of developing Barrett’s esophagus, according to a report in the…
NEW YORK (Reuters Health) – Breastfeeding, both exclusive and partial, appears to lower the risk of sudden infant death syndrome (SIDS), according to a report in the March…
NEW YORK (Reuters Health) – Although it is safe, low-dose vitamin K used to treat warfarin recipients with high INRs (international normalized ratios) does not reduce episodes of…
NEW YORK (Reuters Health) – People who sustain a traumatic brain injury, even of mild severity, remain at increased risk for epilepsy for at least 10 years, according…
NEW YORK (Reuters Health) – New research indicates that when it comes to children’s shoes, the size listed by the manufacturer is rarely the true size. In nearly…
NEW YORK (Reuters Health) – New evidence indicates that elevated serum levels of ionized calcium may predict the risk of death from prostate cancer. If verified in future…
NEW YORK (Reuters Health) – Seven years from now it is very unlikely there will be enough surgeons in the US to perform the estimated 427,500 total hip…
NEW YORK (Reuters Health) – In a phase I trial involving patients with advanced squamous cell carcinoma of the head and neck (SCCHN), direct intratumoral injection of epithelial…
